4//SEC Filing
VINCENT RICHARD G 4
Accession 0001209191-23-024263
CIK 0001260990other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 6:00 AM ET
Size
6.5 KB
Accession
0001209191-23-024263
Insider Transaction Report
Form 4
VINCENT RICHARD G
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-04-13$0.30/sh+30,000$8,961→ 156,859 total
Holdings
- 4,526(indirect: By Trust)
Common Stock
- 1,834(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.2975 to $0.3000. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001269341
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 6:00 AM ET
- Size
- 6.5 KB